1,3-二氟-5-(氟甲基)苯 | 170646-72-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,3-二氟-5-(氟甲基)苯
• 英文名称: 1,3-Difluoro-5-(fluoromethyl)benzene
• CAS: 170646-72-7
• 化学式: C₇H₅F₃
• 分子量: 146.11
• InChiKey: WRYYJVCGOUUTOA-UHFFFAOYSA-N

物化性质

• 沸点：
  127.0±25.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] MORPHOLINONE COMPOUNDS AS FACTOR IXA INHIBITORS<br/>[FR] COMPOSÉS DE MORPHOLINONE EN TANT QU'INHIBITEURS DE FACTEUR IXA
  申请人：MOCHIDA PHARM CO LTD

  公开号：WO2010065717A1

  公开（公告）日：2010-06-10

  The present invention provides a compound of Formula (I) as described herein, or a pharmaceutically acceptable salt or a solvate thereof. The present invention also provides pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.

  本发明提供了如下描述的化合物I的化合物，或其药用可接受的盐或溶剂。本发明还提供包含一个或多个所述化合物的药物组合物，以及使用所述化合物治疗或预防血栓、栓塞、高凝血性或纤维变化的方法。
• SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG
  申请人：Takahashi Chika

  公开号：US20130197219A1

  公开（公告）日：2013-08-01

  The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.

  本发明提供了一种具有抗病毒效果的化合物，特别是对流感病毒具有生长抑制活性，该化合物的首选例子是一种具有依赖帽端核酸酶抑制活性的取代3-羟基-4-吡啶酮衍生物前药。
• [EN] GLUCOCEREBROSIDASE MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE GLUCOCÉRÉBROSIDASES ET LEURS UTILISATIONS
  申请人：ALECTOS THERAPEUTICS INC

  公开号：WO2015095963A1

  公开（公告）日：2015-07-02

  The invention provides isofogamine analogs of structural formula (I) below that modulate and stabilize glucocerebrosidases and enhance their enzymatic activity in vivo. Such compounds, prodrugs and compositions thereof are useful in treating synucleinopathy, lysosomal storage disease and relevant neurodegenerative disease.

  该发明提供了下面结构式（I）的异佛胺类似物，可以调节和稳定葡萄糖酸酯酶，并增强其在体内的酶活性。这些化合物、前药和其组合物对于治疗α突触核蛋白病、溶酶体贮积症和相关的神经退行性疾病非常有用。
• SUBSTITUTED POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE
  申请人：Shionogi & Co., Ltd.

  公开号：EP2444400A1

  公开（公告）日：2012-04-25

  This invention provides compounds having antiviral activities especially inhibiting activity for influenza virus, more preferably provides substituted 3-hydroxy-4-pyridone derivatives having cap-dependent endonuclease inhibitory activity.

  本发明提供了具有抗病毒活性，特别是对流感病毒有抑制活性的化合物，更优选提供了具有帽依赖性内切酶抑制活性的取代 3-羟基-4-吡啶酮衍生物。
• ARENAVIRUS GROWTH INHIBITOR COMPRISING POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE
  申请人：National University Corporation Hokkaido University

  公开号：EP3815689A1

  公开（公告）日：2021-05-05

  The present invention provides a compound having antiviral activity, especially having arenavirus proliferation inhibitory activity, and/or a medicament comprising the compound. More preferably, the present invention provides a compound having proliferation inhibitory activity on the Old World arenaviruses such as Luna virus, Lassa virus, and lymphocytic choriomeningitis virus and/or the New World arenaviruses such as Junin virus, and/or a medicament comprising the compound. An arenavirus proliferation inhibitor comprising a compound represented by Formula (I) or a prodrug thereof or a pharmaceutically acceptable salt thereof: (wherein R1 is carboxy, or the like; A3 is CR2 or N; R2 is a hydrogen atom, halogen, hydroxy, or the like; R3 is a hydrogen atom, hydroxy, carboxy, cyano, formyl, alkyl optionally substituted with Substituent group F, or the like; either A1 or A2 is CR5R6, and the other is NR7, or A1 is CR8R9, and A2 is CR10R11; and R5, R6, R7, R8, R9, R10, and R11 are each independently a hydrogen atom, carboxy, cyano, alkyl optionally substituted with Substituent group F, or the like).

  本发明提供了一种具有抗病毒活性的化合物，尤其是具有抑制禽流感病毒增殖活性的化合物，和/或包含该化合物的药物。更优选地，本发明提供了一种化合物，该化合物对旧大陆病毒（如卢纳病毒、拉萨病毒和淋巴细胞色素膜炎病毒）和/或新大陆病毒（如朱宁病毒）具有增殖抑制活性，和/或包含该化合物的药物。 一种由式（I）代表的化合物或其原药或其药学上可接受的盐组成的腺病毒增殖抑制剂： (其中 R1 是羧基或类似物；A3 是 CR2 或 N；R2 是氢原子、卤素、羟基或类似物；R3 是氢原子、羟基、羧基、氰基、甲酰基、任选被取代基 F 取代的烷基或类似物；A1 或 A2 是 CR5R6，另一个是 NR7，或 A1 是 CR8R9，A2 是 CR10R11；以及 R5、R6、R7、R8、R9、R10 和 R11 各自独立地是氢原子、羧基、氰基、任选被取代基 F 取代的烷基或类似基团）。